Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Interest & Investment Income (2016 - 2025)

Medifast (MED) has disclosed Interest & Investment Income for 16 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income rose 49.0% year-over-year to $1.4 million, compared with a TTM value of $5.5 million through Dec 2025, up 14.8%, and an annual FY2025 reading of $5.5 million, up 14.82% over the prior year.
  • Interest & Investment Income was $1.4 million for Q4 2025 at Medifast, roughly flat from $1.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.4 million in Q3 2025 and bottomed at -$261000.0 in Q3 2022.
  • Average Interest & Investment Income over 5 years is $593950.0, with a median of $707500.0 recorded in 2023.
  • The sharpest move saw Interest & Investment Income crashed 513.04% in 2022, then soared 775.69% in 2024.
  • Year by year, Interest & Investment Income stood at -$93000.0 in 2021, then crashed by 94.62% to -$181000.0 in 2022, then surged by 749.72% to $1.2 million in 2023, then dropped by 18.96% to $953000.0 in 2024, then surged by 49.0% to $1.4 million in 2025.
  • Business Quant data shows Interest & Investment Income for MED at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.4 million in Q2 2025.